Truth Social post of February 11, 2026

PostStatementPublished 02/11Open the original

Summary

President Trump shares news that TrumpRx.gov is bringing immediate prescription drug price relief to millions.

By industry

Healthcare & Drug Pricing1 trading day+1.6%p15 stocks5 trading days+3.5%p15 stocks20 trading days+2.1%p15 stocks

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/02/10	0.0%	0.0%
26/02/11	+1.5%	−0.1%
26/02/12	+1.1%	−1.6%
26/02/13	+2.6%	−1.7%
26/02/17	+2.7%	−1.6%
26/02/18	+2.4%	−1.1%
26/02/19	+1.9%	−1.3%
26/02/20	+1.6%	−0.6%
26/02/23	+2.3%	−1.5%
26/02/24	+1.6%	−0.9%
26/02/25	+1.9%	+0.2%
26/02/26	+1.6%	−1.0%
26/02/27	+3.6%	−1.3%
26/03/02	+3.0%	−1.2%
26/03/03	+1.5%	−2.1%
26/03/04	+1.8%	−1.1%
26/03/05	−0.6%	−1.9%
26/03/06	−0.9%	−3.1%
26/03/09	−0.4%	−2.6%
26/03/10	−1.1%	−2.3%
26/03/11	−1.1%	−3.2%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Steven H. CollisDirector
BuyElevance Health
Buy
Elevance Health
ELV
$869.5K
3,000 sh
$869.5K
Filed 03/06
Traded 03/05
Joaquin DuatoCEO and Chairman
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$11.3M
51,218 sh
$11.3M
Filed 01/28
Traded 01/26
Joaquin DuatoCEO and Chairman
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$10.8M
48,782 sh
$10.8M
Filed 01/28
Traded 01/26
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$8.1M
33,386 sh
$8.1M
Filed 02/18
Traded 02/17
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$6.1M
24,961 sh
$6.1M
Filed 02/18
Traded 02/17
Caroline LitchfieldEVP & CFO
SellMerck
Sell
Merck
MRK
$5M
41,997 sh
$5M
Filed 02/06
Traded 02/04
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$4.7M
19,241 sh
$4.7M
Filed 02/18
Traded 02/17
Robert M. DavisChairman, CEO & President
SellMerck
Sell
Merck
MRK
$3.8M
32,462 sh
$3.8M
Filed 02/06
Traded 02/04
Timothy SchmidEVP, WW Chair, MedTech
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$3.3M
13,625 sh
$3.3M
Filed 02/18
Traded 02/18
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$2.9M
12,066 sh
$2.9M
Filed 02/18
Traded 02/17
Timothy SchmidEVP, WW Chair, MedTech
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$2.2M
8,998 sh
$2.2M
Filed 02/18
Traded 02/18
Robert M. DavisChairman, CEO & President
SellMerck
Sell
Merck
MRK
$1.8M
14,972 sh
$1.8M
Filed 02/06
Traded 02/04
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$17.3M
115,640 sh
$17.3M
Filed 02/06
Traded 02/05
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$15.6M
115,640 sh
$15.6M
Filed 01/26
Traded 01/23
Esteban SantosEVP, Operations
SellAmgen
Sell
Amgen
AMGN
$11.6M
30,501 sh
$11.6M
Filed 03/02
Traded 02/26
Esteban SantosEVP, Operations
SellAmgen
Sell
Amgen
AMGN
$9.2M
24,291 sh
$9.2M
Filed 03/02
Traded 02/26
John C. ReedEVP, Innovative Medicine, R&D
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$7.3M
29,927 sh
$7.3M
Filed 02/18
Traded 02/17
Jennifer ZacharyEVP, General Counsel
SellMerck
Sell
Merck
MRK
$6.8M
56,792 sh
$6.8M
Filed 02/09
Traded 02/09
James D. SwansonEVP, Cio
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$5.4M
22,191 sh
$5.4M
Filed 02/18
Traded 02/13
John C. ReedEVP, Innovative Medicine, R&D
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$5.3M
21,721 sh
$5.3M
Filed 02/18
Traded 02/17